Health Affairs, 24, no. 3 (2005): 622-630 doi: 10.1377/hlthaff.24.3.622 © 2005 by Project HOPE	New Online   House Health Reform Bill   Paying for Reform   Vetting AHIP's Report   HIV/AIDS Costs   Brief: Insurance Reform   HA Blog Top 10

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Offit, P. A. Search for Related Content PubMed PubMed Citation Articles by Offit, P. A. Related Collections Health Promotion/Disease Prevention International Issues Pharmaceuticals Public Health Research And Technology Consumer Issues Vaccines

Infrastructure

Why Are Pharmaceutical Companies Gradually Abandoning Vaccines?

During the past fifty years, the number of pharmaceutical companies making vaccines has decreased dramatically, and those that still make vaccines have reduced resources to make new ones. Pharmaceutical companies are gradually abandoning vaccines because the research, development, testing, and manufacture of vaccines are expensive and because the market to sell vaccines is much smaller than the market for other drug products. Congressional action could assure both a steady supply of existing vaccines and the promise of vaccines for the future.

                      What's this?

This article has been cited by other articles:

				M. M. Mello and T. A. Brennan Legal Concerns and the Influenza Vaccine Shortage JAMA, October 12, 2005; 294(14): 1817 - 1820. [Full Text] [PDF]

				S. A. Plotkin Why Certain Vaccines Have Been Delayed Or Not Developed At All Health Aff., May 1, 2005; 24(3): 631 - 634. [Abstract] [Full Text] [PDF]